The ZNF217 oncogene is a candidate organizer of repressive histone modifiers

被引:67
作者
Banck, Michaela S. [2 ]
Li, Side
Nishio, Hitomi
Wang, Cheng [2 ]
Beutler, Andreas S. [2 ]
Walsh, Martin J. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pediat & Struct & Chem Biol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Med Hematol Oncol, New York, NY USA
关键词
ZNF217; histone modifying enzymes; repressive complexes; oncogene; gene regulation; BREAST-CANCER; TRANSCRIPTIONAL REPRESSION; NUCLEAR RECEPTORS; GENE ACTIVATION; COMPLEX; BINDING; PROTEIN; CELLS; METHYLTRANSFERASE; IDENTIFICATION;
D O I
10.4161/epi.4.2.7953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The zinc finger protein 217 (ZNF217) is an important oncogene based on the high frequency of amplification and overexpression in many cancer types, but its molecular mode of gene regulation is poorly understood. We purified a complex of nuclear ZNF217-binding proteins by affinity chromatography and identified its components by mass spectrometry as Jarid1b/Plu-1, G9a, LSD1, CoREST and CtBP1. Individual binding of these with ZNF217 was confirmed by co-immunoprecipiation (IP). Known activities of these proteins suggested a role of the ZNF217 complex in histone modification. Using in vitro assays the following activities were demonstrated: Histone H3 lysine 4 trimethyl (H3K4me3) demethylase activity, which co-fractionated with Jarid1b/Plu-1 in anion-exchange chromatography; H3K9 methylation, the known principal activity of G9a; and H3K27 methylation. The latter suggested EZH2 as another ZNF217 binding candidate, which could be confirmed by co-IP. Taken together, these findings suggest that ZNF217 assembles a distinct set of histone modifying proteins at target DNA sites that act synergistically in transcriptional repression.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 32 条
[1]   PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: A new cancer/testis antigen? [J].
Barrett, A ;
Madsen, B ;
Copier, J ;
Lu, PJ ;
Cooper, L ;
Scibetta, AG ;
Burchell, J ;
Taylor-Papadimitriou, J .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (06) :581-588
[2]   The complex language of chromatin regulation during transcription [J].
Berger, Shelley L. .
NATURE, 2007, 447 (7143) :407-412
[3]   Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence [J].
Cowger, J. J. M. ;
Zhao, Q. ;
Isovic, M. ;
Torchia, J. .
ONCOGENE, 2007, 26 (23) :3378-3386
[4]   Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors [J].
Florens, Laurence ;
Carozza, Michael J. ;
Swanson, Selene K. ;
Fournier, Marjorie ;
Coleman, Michael K. ;
Workman, Jerry L. ;
Washburn, Michael P. .
METHODS, 2006, 40 (04) :303-311
[5]   Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors [J].
Garcia-Bassets, Ivan ;
Kwon, Young-Soo ;
Telese, Francesca ;
Prefontaine, Gratien G. ;
Hutt, Kasey R. ;
Cheng, Christine S. ;
Ju, Bong-Gun ;
Ohgi, Kenneth A. ;
Wang, Jianxun ;
Escoubet-Lozach, Laure ;
Rose, David W. ;
Glass, Christopher K. ;
Fu, Xiang-Dong ;
Rosenfeld, Michael G. .
CELL, 2007, 128 (03) :505-518
[6]  
Glass CK, 2000, GENE DEV, V14, P121
[7]   Applicability of tandem affinity purification MudPIT to pathway proteomics in yeast [J].
Graumann, J ;
Dunipace, LA ;
Seol, JH ;
McDonald, WH ;
Yates, JR ;
Wold, BJ ;
Deshaies, RJ .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (03) :226-237
[8]   A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes [J].
Hakimi, MA ;
Bochar, DA ;
Chenoweth, J ;
Lane, WS ;
Mandel, G ;
Shiekhattar, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7420-7425
[9]   A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes [J].
Hakimi, MA ;
Dong, Y ;
Lane, WS ;
Speicher, DW ;
Shiekhattar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7234-7239
[10]   ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction [J].
Huang, GQ ;
Krig, S ;
Kowbel, D ;
Xu, HM ;
Hyun, B ;
Volik, S ;
Feuerstein, B ;
Mills, GB ;
Stokoe, D ;
Yaswen, P ;
Collins, C .
HUMAN MOLECULAR GENETICS, 2005, 14 (21) :3219-3225